Marc J. Semigran

Active 1994–2025

71
Papers
21,050
Citations
63
h-index
68
i10-index

Citations

Citations per year for Marc J. Semigran1960: 1 citations1971: 1 citations1992: 1 citations1995: 1 citations1996: 13 citations1997: 28 citations1998: 56 citations1999: 63 citations2000: 86 citations2001: 77 citations2002: 72 citations2003: 70 citations2004: 63 citations2005: 60 citations2006: 80 citations2007: 71 citations2008: 64 citations2009: 69 citations2010: 81 citations2011: 72 citations2012: 130 citations2013: 171 citations2014: 158 citations2015: 177 citations2016: 237 citations2017: 221 citations2018: 188 citations2019: 709 citations2020: 688 citations2021: 572 citations2022: 453 citations2023: 324 citations2024: 487 citations2025: 223 citations2026: 2 citations1961–1970: no citations, so these years are not shown1972–1991: no citations, so these years are not shown1993–1994: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,563 citing papers, 28.3% of this breakdownItaly: 648 citing papers, 7.2% of this breakdownUnited Kingdom: 608 citing papers, 6.7% of this breakdownGermany: 557 citing papers, 6.1% of this breakdownCanada: 395 citing papers, 4.4% of this breakdownNetherlands: 360 citing papers, 4% of this breakdownChina: 306 citing papers, 3.4% of this breakdownFrance: 291 citing papers, 3.2% of this breakdownSpain: 250 citing papers, 2.8% of this breakdownJapan: 242 citing papers, 2.7% of this breakdownAustralia: 213 citing papers, 2.3% of this breakdownSwitzerland: 187 citing papers, 2.1% of this breakdown
0%28.3%Other 26.8%

Fields

  • Medicine75.7%
  • Biochemistry, Genetics and Molecular Biology17.1%
  • Engineering3.9%
  • Neuroscience0.9%
  • Immunology and Microbiology0.7%
  • Health Professions0.6%
  • Other1.1%

Topics

  • Cardiovascular Function and Risk Factors9.3%
  • Heart Failure Treatment and Management8.9%
  • Pulmonary Hypertension Research and Treatments4.2%
  • Cardiovascular and exercise physiology2.7%
  • Cardiac Structural Anomalies and Repair2.4%
  • Mechanical Circulatory Support Devices2.3%
  • Other70.2%

Coauthors

All papers

Open in search
  1. Diuretic Strategies in Patients with Acute Decompensated Heart Failure

    Authors: , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2011 cited by 1,692

  2. The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: A 10-year update

    Authors: , , , , , , , , , , , , , , , - The Journal of Heart and Lung Transplantation 2016 cited by 1,423

  3. Ultrafiltration in Decompensated Heart Failure with Cardiorenal Syndrome

    Authors: , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2012 cited by 984

  4. Effect of Phosphodiesterase-5 Inhibition on Exercise Capacity and Clinical Status in Heart Failure With Preserved Ejection Fraction

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , for the RELAX Trial - JAMA 2013 cited by 1,130

  5. Mavacamten Treatment for Obstructive Hypertrophic Cardiomyopathy

    Authors: , , , , , , , , , - Annals of Internal Medicine 2019 cited by 298

  6. Isosorbide Mononitrate in Heart Failure with Preserved Ejection Fraction

    Authors: , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2015 cited by 538

  7. Clinical Outcomes for Peripartum Cardiomyopathy in North America

    Authors: , , , , , , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2015 cited by 515

  8. Effect of Oral Iron Repletion on Exercise Capacity in Patients With Heart Failure With Reduced Ejection Fraction and Iron Deficiency

    Authors: , , , , , , , , , , , , , , , , , - JAMA 2017 cited by 452

  9. Cardiovascular Phenotype in HFpEF Patients With or Without Diabetes

    Authors: , , , , , , , , , , - Journal of the American College of Cardiology 2014 cited by 210

  10. Addressing Common Questions Encountered in the Diagnosis and Management of Cardiac Amyloidosis

    Authors: , , , , - Circulation 2017 cited by 486

  11. Metabolic Signatures of Exercise in Human Plasma

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Science Translational Medicine 2010 cited by 423

  12. Low-Dose Dopamine or Low-Dose Nesiritide in Acute Heart Failure With Renal Dysfunction

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Monica Shah, Adrian F. Hernandez, Eugene Braunwald, Margaret M. Redfield - JAMA 2013 cited by 501

  13. Amyloidogenic light chains induce cardiomyocyte contractile dysfunction and apoptosis via a non-canonical p38α MAPK pathway

    Authors: , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2010 cited by 330

  14. Pulmonary Hypertension in Chronic Lung Diseases

    Authors: , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2013 cited by 679

  15. Effects of Xanthine Oxidase Inhibition in Hyperuricemic Heart Failure Patients

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Circulation 2015 cited by 293

  16. Impaired Left Ventricular Global Longitudinal Strain in Patients with Heart Failure with Preserved Ejection Fraction: Insights from the RELAX Trial

    Authors: , , , , , , , , , , , , - European Journal of Heart Failure 2017 cited by 183

  17. Riociguat for Patients With Pulmonary Hypertension Caused by Systolic Left Ventricular Dysfunction

    Authors: , , , , , , , , , , - Circulation 2013 cited by 325

  18. Pulmonary Hypertension Due to Left Heart Diseases

    Authors: , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2013 cited by 629

  19. Inhibition of ErbB2 causes mitochondrial dysfunction in cardiomyocytes

    Authors: , , , , , , - Journal of the American College of Cardiology 2004 cited by 236

  20. Determinants of Ventilatory Efficiency in Heart Failure

    Authors: , , , , - Circulation Heart Failure 2008 cited by 164

  21. Apoptosis in heart failure: Release of cytochrome c from mitochondria and activation of caspase-3 in human cardiomyopathy

    Authors: , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 1999 cited by 586

  22. Sildenafil Improves Exercise Capacity and Quality of Life in Patients With Systolic Heart Failure and Secondary Pulmonary Hypertension

    Authors: , , , , , , , , , , - Circulation 2007 cited by 513

  23. The Six-Minute Walk Test Predicts Peak Oxygen Uptake and Survival in Patients With Advanced Heart Failure

    Authors: , , , , - CHEST Journal 1996 cited by 762

  24. Placental senescence pathophysiology is shared between peripartum cardiomyopathy and preeclampsia in mouse and human

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Zoltàn Arany, Dennis M. McNamara, Dennis M. McNamara, Denise Hilfiker‐Kleiner, Anthony Rosenzweig, James D. Fett, Jessica Pisarcik, Charles F. McTiernan, Erik B. Schelbert, Rami Alharethi, Kismet Rasmusson, Kim Brunisholz, Amy L. Butler, D. Budge, Abdallah G. Kfoury, Benjamin D. Horne, Joe Tuinei, Heather Brown, Allen J. Naftilan, Jill Russell, Darla Freehardt, Eileen Hsich, Cynthia Oblak, Greg Ewald, Donna Whitehead, Jean Flanagan, Anne Platts, Uri Elkayam, Jorge Caro, Stephanie Mullin, Michael M. Givertz, Mary Susan Anello, Navin Rajagopalan, David R. Booth, Tiffany Sandlin, Wendy Wijesiri, Leslie T. Cooper, Lori A. Blauwet, Joann Brunner, Mary Phelps, Ruth Kempf, Kalgi Modi, Tracy Norwood, Joan Briller, Decebal Sorin Griza, G. Michael Felker, Robb D. Kociol, Patricia L. Adams, Gretchen Wells, Vinay Thohan, Deborah Wesley-Farrington, Sandra Soots, Richard Sheppard, Caroline Michel, Nathalie Lapointe, Heather Nathaniel, Angela Kealey, Marc J. Semigran, Maureen Daher, John Boehmer, David Silber, Eric Popjes, Patricia Frey, Todd Nicklas, Jeffrey D. Alexis, Lori Caufield, John W. Thornton, Mindy Gentry, V.J. Robinson, Gyanendra K. Sharma and 44 more - Science Translational Medicine 2024 cited by 31